Skip to main content
Journal cover image

76 Preliminary Report of a First-in-human, Open-label, Multicenter, Phase I Study of AT-406 (Debio 1143), an Oral Small Molecule Multi-IAP Inhibitor, in Solid Tumors and Lymphomas

Publication ,  Conference
Hurwitz, H; Pitot, H; Strickler, J; Sorensen, JM; Leopold, L; Brill, J; Smith, DC
Published in: European Journal of Cancer
November 2012

Duke Scholars

Published In

European Journal of Cancer

DOI

ISSN

0959-8049

Publication Date

November 2012

Volume

48

Start / End Page

25 / 25

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1117 Public Health and Health Services
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hurwitz, H., Pitot, H., Strickler, J., Sorensen, J. M., Leopold, L., Brill, J., & Smith, D. C. (2012). 76 Preliminary Report of a First-in-human, Open-label, Multicenter, Phase I Study of AT-406 (Debio 1143), an Oral Small Molecule Multi-IAP Inhibitor, in Solid Tumors and Lymphomas. In European Journal of Cancer (Vol. 48, pp. 25–25). Elsevier BV. https://doi.org/10.1016/s0959-8049(12)71874-9
Hurwitz, H., H. Pitot, J. Strickler, J. M. Sorensen, L. Leopold, J. Brill, and D. C. Smith. “76 Preliminary Report of a First-in-human, Open-label, Multicenter, Phase I Study of AT-406 (Debio 1143), an Oral Small Molecule Multi-IAP Inhibitor, in Solid Tumors and Lymphomas.” In European Journal of Cancer, 48:25–25. Elsevier BV, 2012. https://doi.org/10.1016/s0959-8049(12)71874-9.
Hurwitz H, Pitot H, Strickler J, Sorensen JM, Leopold L, Brill J, et al. 76 Preliminary Report of a First-in-human, Open-label, Multicenter, Phase I Study of AT-406 (Debio 1143), an Oral Small Molecule Multi-IAP Inhibitor, in Solid Tumors and Lymphomas. In: European Journal of Cancer. Elsevier BV; 2012. p. 25–25.
Hurwitz, H., et al. “76 Preliminary Report of a First-in-human, Open-label, Multicenter, Phase I Study of AT-406 (Debio 1143), an Oral Small Molecule Multi-IAP Inhibitor, in Solid Tumors and Lymphomas.” European Journal of Cancer, vol. 48, Elsevier BV, 2012, pp. 25–25. Crossref, doi:10.1016/s0959-8049(12)71874-9.
Hurwitz H, Pitot H, Strickler J, Sorensen JM, Leopold L, Brill J, Smith DC. 76 Preliminary Report of a First-in-human, Open-label, Multicenter, Phase I Study of AT-406 (Debio 1143), an Oral Small Molecule Multi-IAP Inhibitor, in Solid Tumors and Lymphomas. European Journal of Cancer. Elsevier BV; 2012. p. 25–25.
Journal cover image

Published In

European Journal of Cancer

DOI

ISSN

0959-8049

Publication Date

November 2012

Volume

48

Start / End Page

25 / 25

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1117 Public Health and Health Services
  • 1112 Oncology and Carcinogenesis